All the news Showing 7 of 87 articles from: NAFLDGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Cenicriviroc may reduce fibrosis in people with fatty liver disease Liz Highleyman / 05 October 2017 Cenicriviroc, a drug that blocks both CCR5 and CCR2 receptors on immune cells, was associated with a decrease in liver fibrosis in people with non-alcoholic steatosis, a type of fatty ... Switching from efavirenz to raltegravir leads to significant improvements in fatty liver disease in people with HIV Michael Carter / 17 August 2017 Switching to raltegravir from efavirenz is associated with significant improvements in liver steatosis for HIV-positive people with non-alcoholic fatty liver disease, Spanish investigators report in the online edition of Clinical ... Non-alcoholic fatty liver disease common in people living with HIV – metabolic disorders are key risk factors Michael Carter / 19 July 2017 Over a third of people with HIV have non-alcoholic fatty liver disease (NAFLD) in the absence of hepatitis B or C, according to the results of a meta-analysis and systematic ... When you eat may contribute to fatty liver disease as much as what you eat Liz Highleyman / 17 November 2016 People who skip breakfast and eat late at night may have an elevated risk of non-alcoholic fatty liver disease (NAFLD), according to research presented this week at the 2016 AASLD Liver Meeting in ... Coffee consumption linked to reduced liver fibrosis in people with HBV, HCV and NAFLD Liz Highleyman / 08 December 2015 Drinking coffee was associated with lower liver stiffness – a non-invasive measure used to estimate liver fibrosis – in people with hepatitis B, hepatitis C and non-alcoholic fatty liver disease (NAFLD), researchers reported ... Milk thistle may improve steatohepatitis, capsaicin from chilli peppers may slow fibrosis Liz Highleyman / 10 June 2015 People who used silymarin, derived from the milk thistle plant, experienced a resolution of non-alcoholic steatohepatitis (NASH) and a reduction in liver fibrosis in a randomised, placebo-controlled trial, researchers reported at the European ... Liver disease a major cause of illness and death across the EU: action needed to save lives Michael Carter / 10 April 2013 Liver disease is the cause of a considerable burden of illness across the European Union (EU), investigators report in The Journal of Hepatology. The authors calculate that 170,000 deaths each year are attributable ... ← Prev1...56789Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD NASH Experimental treatments for NASH/NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive